This launch builds upon Hikma’s leading position as one of the largest US providers of nasally administered medicines used for treating seasonal allergies and advances its objective of growing its specialty business in the US
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
Subscribe To Our Newsletter & Stay Updated
